Efficacy of artesunate 7days therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Pa-an (Mon State) in Myanmar.
A study evaluating the efficacy and safety of artesunate for the treatment of uncomplicated plasmodium falciparum malaria in Pa-An (Mon State) in Myanmar
Clinical Research Unit ( Malaria), Defense Services General Hospital
50 participants
Jan 20, 2014
Interventional
Conditions
Summary
To study the efficacy of antimalarial drugs in Myanmar
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The patients will be administered artesunate in oral tablet form (50 mg of artesunate per tablet,) at a dose of 4mg/kg/day for 7 days. Each dose administration will be observed and recorded.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12614000215628